The level of amyloid (white shades in area encircled by green dotted lines) – the protein thought to drive neurodegeneration in AD, is high in the brain of AD mouse (left) and reduces after the administration of the genome editing therapy throughout the brain (right).
An international research team led by scientists from the Hong Kong University of Science and Technology (HKUST) has developed a novel strategy using brain-wide genome-editing technology that can reduce Alzheimer’s disease (AD) pathologies in genetically modified AD mouse models. This advanced technology offers immense potential to be translated as a novel long-acting therapeutic treatment for AD patients.
In China alone, over 500,000 patients are estimated to be living with a hereditary form of AD – familial Alzheimer’s disease (FAD), which is a congenital form of AD highly associated with family history. Although FAD has a clear genetic cause and can be diagnosed before cognitive problems occur, no effective treatment currently exists.
There is enormous potential in the use of genome-editing technology1 as therapeutic strategies for diseases caused by inherited mutations, such as FAD. It is especially useful for correcting disease-causing genetic mutations before symptoms appear, for which it is considered a “once-and-for-all” treatment as its effects can last a lifetime. However, several hurdles have prevented its clinical development and application – most notably the lack of an effective, efficient, and non-invasive means to deliver genome-editing agents into the brain. Furthermore, existing genome-editing technologies are unable to generate beneficial outcomes throughout the whole brain.
Recently, a team led by Prof. Nancy Ip, Vice-President for Research and Development at HKUST, developed a new genome-editing system that not only crosses the blood–brain barrier, but also delivers an optimized genome-editing tool to the entire brain. Using a newly engineered delivery vehicle for genome-editing, this strategy achieves efficient brain-wide genome editing through a single non-invasive intravenous administration. This effectively disrupts FAD-inflicted mutations in AD mouse models and ameliorates AD pathologies throughout the entire brain, paving the way to novel therapeutic development for the disease.
Meanwhile, the research team also found in the mouse models that the level of amyloid, a protein thought to drive neurodegeneration in AD, remained low for 6 months post-treatment (about 1/3 of their normal lifespan), demonstrating that this single-shot genome-editing strategy has lasting effects. More importantly, no side effects were detected so far in the mice.
“As the first demonstration of efficient brain-wide genome editing to alleviate Alzheimer’s disease pathology throughout the whole brain, this is really an exciting development,” said Prof. Ip, who is also the Morningside Professor of Life Science and Director of the State Key Laboratory of Molecular Neuroscience at HKUST. “Our work is an important milestone for the use of genome editing in treating hereditary brain diseases, and contributes to the development of precision medicine for inherited forms of neurodegenerative diseases.”
https://youtu.be/39aZtWoOOE0
This research was a collaborative effort among scientists from HKUST; the California Institute of Technology; and the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. The results were recently published in Nature Biomedical Engineering.
Original Article: HKUST Scientists Develop Genome-editing Strategy for Potential Alzheimer’s Disease Therapy
More from: Hong Kong University of Science and Technology | California Institute of Technology | Chinese Academy of Sciences
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Brain-wide genome-editing
- CRISPR-Cas9 genome editing articles from across Nature Portfolio
CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...
- Untangling Brain-wide Interactions Using Data-Constrained Modeling
Behaving animals continually reconcile the internal states of their neural circuits brain-wide with incoming sensory and environmental evidence to evaluate when and how to act. The brains of animals ...
- CRISPR Gene Editing News
New Nanoparticles Deliver Therapy Brain-Wide, Edit Alzheimer's Gene in Mice Jan. 19, 2023 — Researchers describe a new family of nano-scale capsules made of silica that can carry genome-editing ...
- CRISPR and Genome Editing
CRISPR and Genome Editing This page provides educational resources, events, news and products related to CRISPR and genome editing. Content will cover aspects from advances in genetic engineering ...
- CRISPR and Genome Editing
This instalment of Teach Me in 10 features Dr Theo Roth, whose work bridges a number of different fields, such as genome engineering, cancer immunology and cell-based therapies. Scientists have ...
Go deeper with Google Headlines on:
Brain-wide genome-editing
[google_news title=”” keyword=”brain-wide genome-editing” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Genome editing
- BSM arranges workshop on CRISPR-Cas9 Gene Editing: A new era in molecular biology
Bangladesh Society of Microbiologists (BSM) arranged a comprehensive 5-day workshop providing hands-on training on CRISPR experimental design to 20 candidates in the first phase of the workshop ...
- China fast-tracks edited wheat genome as part of food security drive
The edit, which helps the crop resist a common fungal infection, was approved within an unusually short period It is the first wheat genome edit approved in China, which shows country's interest in ...
- Dream Home Giveaway: Meet one St. Jude researcher working to end childhood cancer
St. Jude Children’s Research Hospital is at the forefront of developing treatments thanks to the tireless work of researchers on campus ...
- CRISPR edits fail to cure HIV patients in early test
Excision BioTherapeutics reported Friday that an early trial failed to cure HIV patients, but the company plans to try again with a more efficient editing treatment.
- Team develops efficient host-vector system for a model archaeon by solving CRISPR-based host-plasmid conflict
A research group has constructed versatile genetic tools for Saccharolobus islandicus REY15A, one of the very few archaeal models for archaea biology and CRISPR biology research.
Go deeper with Google Headlines on:
Genome editing
[google_news title=”” keyword=”genome editing” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]